[1] Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16): 1685-1695.
[2] Yayan J. Emerging families of biomarkers for coronary artery disease: inflammatory mediators[J]. Vasc Health Risk Manag, 2013, 9:435-456.
[3] Sari I, Sunbul M, Mammadov C, et al. Relation of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography[J]. Kardiol Pol, 2015, 73(12):1310-1316.
[4] Sonmez O, Ertas G, Bacaksiz A, et al. Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study[J]. Anadolu Kardiyol Derg, 2013, 13(7):662-667.
[5] 张上仕,朱红艳,赵若池,等. 中性粒细胞与淋巴细胞比值对介入治疗后ST段抬高型心肌梗死患者预后预测价值的荟萃分析[J]. 中华心血管病杂志, 2015, 43(3):264-268.
[6] Soylu K, Gedikli O, Dagasan G, et al. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome[J]. Rev Port Cardiol, 2015, 34(7/8):465-471.
[7] Chen J, Chen MH, Li S, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of coronary artery disease: a Gensini score assessment[J]. J Atheroscler Thromb, 2014, 21(12):1271-1282.
[8] 杨伟宪,杨铮,窦克非,等. 217例青年冠心病患者临床特点分析[J]. 中国循环杂志, 2014, 29(5):339-342.
[9] 王贺滋,韩雅玲,荆全民,等. 青年冠心病危险因素与冠状动脉病变程度的相关性分析[J]. 解放军医学杂志, 2011, 36(4):331-335.
[10] Maroszynska-Dmoch EM, Wozakowska-Kaplon B. Clinical and angiographic characteristics of coronary artery disease in young adults: a single centre study[J]. Kardiol Pol, 2016, 74(4):314-321.
[11] Tsai WC, Wu KY, Lin GM, et al. Clinical characteristics of patients less than forty years old with coronary artery disease in Taiwan: a cross-sectional study[J]. Acta Cardiol Sin, 2017, 33(3):233- 240.
[12] 黄帅波,代现良,贺治青,等. 中性粒细胞与淋巴细胞比值评估冠心病预后[J]. 国际心血管病杂志, 2015, 42(2):71-74.
[13] Ozturk S, Erdem A, Ozlu MF, et al. Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes[J]. Turk Kardiyol Dern Ars, 2013, 41(4):284-289.